Hey there! Welcome!
Get updated on
Select Speciality
Top Picks
31 Aug, 26
ESC 2026
Hypertension studies presented at ESC 2026, highlighted advances in personalized BP management, including promising results with long-acting zilebesiran and low-dose combination therapy. The research also revealed important age-, sex-, and phenotype-related differences in hypertension risk, treatment response, and cardiovascular outcomes.
27 Aug, 26
Indian Guidelines on Hypertension update hypertension care in India with evidence-based guidance, new CVD risk stratification, revised BP classification, targets & treatment algorithms, emphasizing FDCs, beta-blockers, & digital health tools.
28 Aug, 26Chest
- Eosinophilic AE-COPD (blood eosinophils ≥300/μL within 3 days before to 1 day after the event), was associated with a significantly lower 1-year risk of major adverse cardiovascular events vs non-eosinophilic AE-COPD
- Eosinophilic AE-COPD was linked to reduced risks of heart failure, myocardial infarction, stroke, arrhythmias, and mortality, highlighting eosinophil count as a valuable cardiovascular risk biomarker.
28 Aug, 26Diabetes Care.
- 4693 women followed for 10-14 yrs postpartum, showed GDM these subtypes: insulin-deficient (3%), insulin-resistant (9%), mixed-defect (1.6%), & unclassified (0.7%)
- Insulin-deficient, insulin-resistant, & mixed-defect GDM were linked to higher risk of prediabetes/diabetes vs no GDM (RR 2.14 to 2.88), metabolic syndrome, & higher predicted CVD risk; dyslipidemia was significant only with insulin-resistant GDM.
27 Aug, 26Lancet Prim Care.
- Amongst a multinational cohort of 5.84 million adults initiating antihypertensive therapy, 1.9% suffered with ADHD
- ADHD was associated with higher risk of MACE (HR:1.31, 95% CI 1.18-1.45) & all-cause mortality (HR:2.83, 95% CI 2.07-3.87)
- After adjustment for psychiatric/cardiometabolic comorbidities, risks attenuated
- ADHD medication was not associated with MACE (HR 1.00) or mortality (HR 0.96)
26 Aug, 26BMC Infect Dis
- A retrospective ICU study of hospital-acquired bloodstream infections caused by carbapenem-resistant and difficult-to-treat Gram-negative bacteria found an extremely high 28-day mortality rate (87.4%)
- Independent mortality predictors included older age, higher SOFA score, COVID-19 co-infection, and aminoglycoside resistance
- Early appropriate empirical antibiotics did not independently improve survival outcomes.
27 Aug, 26
Featured
27 Aug, 26
24 Aug, 26
24 Aug, 26
